IL-23 modulates CD56+/CD3- NK Cell and CD56+/CD3+ NK-like T Cell function differentially from IL-12

International Immunology

Volumn 21, Issue 2, 2009, Pages 145-153

  van de Wetering, Diederik ^a   de Paus, Roelof A ^a   van Dissel, Jaap T ^a   van de Vosse, Esther ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Human; IL 18; IL 23; Innate immunity

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR ALPHA; INTERLEUKIN 23; STAT1 PROTEIN; STAT2 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

ANTIGENS, CD3; ANTIGENS, CD56; CELL PROLIFERATION; CELLS, CULTURED; DRUG SYNERGISM; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOMAGNETIC SEPARATION; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-23; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS;

EID: 59549094650     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn132     Document Type: Article

References (32)

1. Griggs, N. D. and Smith, R. A. 1994. Natural killer cell activity against uninfected and Salmonella typhimurium-infected murine fibroblast L929 cells. Nat. Immunol. 13:42.
2. Kirby, A. C., Yrlid, U. and Wick, M. J. 2002. The innate immune response differs in primary and secondary Salmonella infection. J. Immunol. 169:4450.
3. Feng, C. G., Kaviratne, M., Rothfuchs, A. G. et al. 2006. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis. J. Immunol. 177:7086.
4. Scharton, T. M. and Scott, P. 1993. Natural killer cells are a source of interferon gamma that drives differentiation,of CD4+ T cell subsets and induces early resistance to Leishmania, major in mice. J. Exp. Med. 178:567.
5. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P. and Salazar-Mather, T. P. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
6. Byrne, P., McGuirk, P., Todryk, S. and Mills, K. H. 2004. Depletion of NK cells results in disseminating lethal irdection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34:2579.
7. Martin-Fontecha, A., Thomsen, L. L., Brett, S. et al. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5:1260.
8. van de Vosse, E. and Ottenhoff, T H. 2006. Human host genetic factors in mycobacterial and Salmonella infection: Lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity. Microbes Infect. 8:1167.
9. Verreck, F. A., de Boer, T., Langenberg, D. M. et al. 2004. Human IL-23-producing type 1 macrophpges promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc. Natl Acad. Sci. USA 101:4560.
10. Hunter, C. A., Timans, J., Pisacane, P. et al. 1997. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Eur J. Immunol. 27:2787.
11. Oppmann, B., Lesley, R., Blom, B. et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715.
12. van de Vosse, E., Hoeve, M. A. and Qftenhoff, T. H. 2004. Human genetics of intracellular infectious diseases: Molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect. Dis. 4:739.
13. Gately, M. K., Renzetti, L. M., Magram, J. et al. 1998. The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses. Annu., Rev. Immunol. 16:495.
14. Guia, S., Cognet, C., de Beaucoudrey, L. et al. 2008. A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 111:5008.
15. Hochrein, H., O'Keeffe, M., Luft, T. et al. 2000. Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 192:823.
16. Happel, K. I., Dubin, P. J., Zheng, M. et al. 2005. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae. J. Exp. Med. 202:761.
17. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state qharacterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
18. Vanden Eijnden, S., Goriely, S., De Wit, D., Willems, F. and Goldman, M. 2005. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur. J. Immunol. 35:469.
19. van de Vosse, E., de Paus, R. A., Van Dissel, J. T. and Ottenhoff, T. H. 2005. Molecular complementation of IL-12Rbeta1 deficiency reveals functional differences between IL-12Rbeta1 alleles including partial IL-12Rbeta1 deficiency. Hum. Mol. Genet. 14:3847.
20. Parham, C., Chirica, M., Timans, J. et al. 2002. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168:5699.
21. Takeda, K., Tsutsui, H., Yoshimoto, T. et al. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8:383.
22. de Paus, R. A., van de Wetering, D., Van Dissel, J. T. and van de Vosse, E. 2008. IL-23 and IL-12 responses in activated human T cells retrovirally transduced with IL-23 receptor variants. Mol. Immunol. 45:3889.
23. Lauwerys, B. R., Renauld, J. C. and Houssiau, F. A. 1999. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 11:822.
24. Hayes, M. P., Wang, J. and Norcross, M. A. 1995. Regulation of interleukin-12 expression in human monocytes: Selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646.
25. Thakker, P., Leach, M. W., Kuang, W., Benoit, S. E., Leonard, J. P. and Marusic, S. 2007. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 178:2589.
26. MacLennan, C., Fieschi, C., Lammas, D. A. et al. 2004. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 190:1755.
27. Jason, J., Buchanan, I., Archibald, L. K. et al. 2000. Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections. J. Infect. Dis. 182:474.
28. Barcelos, W., Martins-Filho, O. A., Guimaraes, T. M. et al. 2006. Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment. Microbiol. Immunol. 50:597.
29. Veenstra, H., Baumann, R., Carroll, N. M. et al. 2006. Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3dimCD56+ natural killer Tcells in fast treatment responders. Clin. Exp. Immunol. 145:252.
30. Cooper, A. M., Kipnis, A., Turner, J., Magram, J., Ferrante, J. and Orme, I. M. 2002. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168:1322.
31. Lehmann, J., Bellmann, S., Werner, C., Schroder, R., Schultze, N. and Alber, G. 2001. IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella enteridis. J. Immunol. 167:5304.
32. Khader, S. A., Pearl, J. E., Sakamato, K. et al. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFNgamma responses if IL-12p70 is available. J. Immunol. 175:788.